Acute renal failure (ARF) in the critically ill patient is accompanied by severe alterations in cellular metabolism that enhance protein catabolism and impair cellular ability to maintain homestasis. As a consequence, many patients with ARF due to post-surgical or septic conditions show a sharp increase in protein breakdown and energy expenditure (1) . However ARF in a critically ill patient represents only one manifestation of the underlying disease (2) , and its role in determining prognosis is of minor importance (3, 4) . Conversely, hypercatabolism and malnutrition may be crucial for the illness outcome (5-7), by impairing body resistance to many agents and possibly favoring the development of multiple organ failure (MOF) (8) .
Metabolic abnormalities due to uraemia per se
Uraemia impairs the activity of many enzymatic pathways, leading to ineffective substrate utilization and defective cellular energy metabolism (9) (10) (11) (12) . The simultaneous occurrence of glucose intolerance and protein hypercatabolism is a known metabolic feature of ARF. While a post-receptor defect in insulin action is responsible for the glucose intolerance (9) , the role of insulin resistance in protein catabolism remains unclear. Indeed, aminoacid uptake by skeletal muscle is normal following insulin administration (9) but insulin stimulated synthesis is depressed (13, 14) . Thus although a reduction in protein synthesis might contribute to altered protein metabolism, the increase in protein degradation is primarily responsible for protein hypercatabolism in ARF (13) .
Independently of the pathogenetic mechanisms of metabolic alterations in renal insufficiency, numerous studies have shown that the degree of protein hypercatabolism is strictly related to the severity of the carbohydrate, lipid and energy defects (11 ) .
Elevated plasma levels of glucagon, corticosteroids, and parathyroid hormone have also been implicated in the genesis of these metabolic abnormalities. More recently, metabolic acidosis has been identified as a cause of excessive muscle proteolysis in uraemic rats, an effect partially mediated by glucocorticoid hyperproduction (14) . A stimulation in branchedchain aminoacid oxidation in skeletal muscle is thought to be responsible, at least in part, for the abnormal turnover of proteins during metabolic acidosis (15) . The relevance of acidosis in protein hypercatabolism of ARF is still under evaluation, but nitrogen balance can improve when acidosis is corrected in patients with chronic uraemia (16) .
Hormonal and metabolic responses to starvation
Many patients with ARF cannot eat because of nausea, vomiting, or their underlying illness. The first metabolic response to starvation is glucose release from glycogen due to the decrease in insulin concentration and a simultaneous rise in circulating levels of glucagon. A fall in plasma glucose is thus prevented and adequate glucose supply is maintained to the brain and kidneys. Since hepatic glycogen stores are exhausted within 12-24 hours, near normal glucose concentration is maintained through gluconeogenesis by an increase in aminoacid release from muscle proteins.
During starvation corticosteroids and glucagon enhance aminoacid release from muscles and stimulate gluconeogenesis and ureagenesis in the liver. About 30-40% of the aminoacids released from peripheral tissues consist of alanine and glutamine, which however represent only a small fraction of the muscle aminoacid pool. Glutamine is also converted in the small bowel to alanine which enters the circulation and is used in the liver as the major substrate for gluconeogenesis.
As the normal individual continues to fast a phase of adaptation ensues. Gluconeogenesis and protein catabolism progressively decrease, as evidenced by a diminution in urea-nitrogen production. Energy is now mainly supplied by the oxidation of fatty acids. Their mobilization from adipocytes and utilization in the liver and peripheral tissues is stimulated by the fall in insulin level and a relative increase in glucagon and growth hormone concentrations .. Ketone bodies constitute the major metabolic fuel in the brain and, together with fatty acids, in many other organs.
In addition to the decrease in protein catabolism a decline in body energy consumption is also evident. Hormonal and metabolic responses to starvation are summarized in Table I .
The metabolic response to stress
In the critically ill patient the metabolic pattern resembles only partially that observed in the starving unstressed patient (17) (18) (19) (20) (21) (22) .
A common feature is the activation of muscle proteolysis and gluconeogenesis. But whereas starvation is characterized by normal or low glucose levels and hypoinsulinemia, the stressed patient often has high circulating levels of both glucose and insulin. Moreover energy expenditure, reduced in starvation, is increased from at least 15% to more than 100%. In starvation, gluconeogenesis may be inhibited by small amounts of glucose; but in the stressed patient it is refractory to glucose administration (23) and may be inhibited only by huge infusions of glucose (24) . Several studies suggest that glucose turnover is abnormal in critically ill patients (8, 21, (23) (24) (25) (26) (27) (28) . Both an elevated rate of glucose production and a relative impairment in the oxidative capacity for glucose have been demonstrated, and glucose recycling accounts for most of the increment of gluconeogenesis.
A key role in glucose metabolism in played by the branched-chain aminoacids (BCAA) leucine, isoleucine, and valine, which may undergo oxidation in muscle itself as a primary energy source (29, 30) . BCAA oxidation, however, is coupled with gluconeogenesis and glucose recycling, since muscle pyruvate and glutamate are converted to alanine and glutamine by accepting BCAA aminonitrogen during transamination reactions (28, 29, 31 ) .
As a consequence, the final mixture of aminoacids Fat metabolism has been less intensively studied in acute patients. Many authors believe that because of the impairment of glucose metabolism body fuel oxidation shifts toward oxidation of fat to supply energy metabolism (8, 34) . In fact, an increased rate of both fatty acid release from adipocytes (35, 36) and fatty acid oxidation in muscles (34, 37) have been reported.
However, alterations in fat turnover with increment in fatty acid recycling and triglyceride synthesis have also been demonstrated (28, (38) (39) (40) . Both epinephrine and growth hormone, elevated in critically ill patients (41) , may be involved in the accelerated lipolysis; and insulin hypersecretion may be responsible for stimulating triglyceride synthesis.
In contrast to the fasting state, the increased mobilization of endogenous fat stores does not increase hepatic ketogenesis, and the utilization rate of ketone bodies in muscle is lower than normal (42) (43) (44) . Since ketone bodies may serve as primary endogenous energy substrate during starvation, it has been suggested that the lack of ketotic response in the stressed patient might contribute to fuel deficiency in muscles and possibility to protein hypercatabolism. Table II shows the main differences in hormonal and metabolic responses to simple starvation and to the stressed state.
Hypermetabolism and the multiple organ failure syndrome
In the critically ill patient a sequence of functional alterations may culminate in a widespread organ failure syndrome (8, 40) .
Irrespective of the etiology of the initiating event, these changes tend to limit the extent and magnitude of injury (45) (46) (47) (48) (49) . Cellular metabolism is hyperactive and energy consumption is enhanced. The clinical picture is characterized by high cardiac output, low systemic vascular resistance, and increased oxygen consumption (8, 40) . (39) . These tissues are rich in mononuclear phagocytes, which are predominantly glycolytic and likely to be in a highly activated state. Since both gluconeogenesis and protein synthesis in the splachnic bed use nitrogenous substrates mobilized from muscle cells, skeletal muscle wasting is the price paid for the development of an effective response to injury.
The hypermetabolic state subsides in about 7-8 days if the patient recovers. If sepsis, tissue injury, or perfusion deficit persist multiple organ failure (MOF), ensues beginning with the lungs and then affecting the kidneys and the liver (40) . This clinical setting is characterized by arterial hypotension, reduced cardiac output, decreased tissue perfusion, and decreased oxygen consumption (50) . Protein hypercatabolism is reduced, as is urea production (51). The rise in serum bilirubin concentration is associated with a significant increase in mortality risk (40) . Patient's death comes at about 14 to 21 days after the initial event, and according to our experience about 6 days after the sharp increase in bilirubinemia.
Increasing evidence suggests that many of the systemic responses occurring after injury and infection are related to host-elaboration of local or circulating factors (39, 48, 49, 52-56). For many years a variety of glucoregulatory hormones have been involved, and more recently eicosanoids of arachidonic acid, including prostaglandins, have also been implicated. Cytokines are the primary mediators of acute-phase response and of these the interleukin 1 and 2 and tumor necrosis factor/cachectin (TNF) initiate many of the events (49, 54, 57) . Cytokines, produced by activated lymphocytes and macrophages, play a pivotal role in eliciting immunological, inflammatory, and metabolic responses to injury and infection. They also stimulate the increase in circulating counterregulatory hormone levels and prostaglandin release.
Much evidence that TNF has a primary role in the response to injury comes from animal models. The infusinn of TNF in dogs and rats has the same effect as endotoxic and septic shock (58, 59) ; and chronic administration of TNF induces nutritional and body composition changes resembling those of prolonged stress states (60) . Moreover, pretreatment with specific antibody against TNF protects animals against the lethal effects of endotoxin or bacterial infusions (61, 62) . In animals TNF-induced cachexia mimics human cachexia in that liver mass is preserved, while in simple starvation liver mass in reduced in proportion to body weight loss and skeletal muscle wasting (49) .
In man raised plasma TNF levels have been found after endotoxin administration to normal volunteers (53); and TNF administration induces changes similar to those observed after endotoxin infusion (63) . Although the detection of circulating TNF is problematic for the low sensitivity level of current assays, there is preliminary evidence that increased TNF levels worsen the outcome in septic patients (64, 65) .
Most of the changes in the intermediary metabolism of the stressed state may be reproduced in experimental animals and in humans by the infusion of crude extracts from stimulated macrophages or of purified mediators. Hyperglycemia accompained by an increased glucose turnover rate, accelerated muscle proteolysis, and hypertriglyceride mia have been documented after cytokine administration (48) .
Nutritional treatment of acute renal failure
In patients without hypercatabolic ARF, limited amounts of carbohydrates are sufficient to prevent protein hypercatabolism . A protein-restricted diet (15 to 20 grams of protein/day). supplemented with essential aminoacids (8-12 grams/day), may reduce the need for hemodialysis (66) . To the same purpose a diet containing 0.6 grams of protein/kg b.w. and 35 kcal/kg is also commonly recommended (67) . When oral nutrition is incomplete, intravenous supplementation with 100 gram.s of glucose and essential aminoacids -10 to 20 grams/day -may be indicated for slowing the rate of rise of BUN.
In hypercatabolic patients, however, nutritional support becomes very important. Nutrients in amounts adequate to meet metabolic needs are required to 128 heal tissues and support the immune system. Although the hypermetabolic response can be tolerated for a short period of time, continued hypercatabolism depletes body proteins and fuels, rendering patients susceptible to complications (6, 68) . Infections and sepsis remain the primary cause of death in trauma patients who live at least 5-7 days after injury (69, 70) ; the increased sepsis related mortality in surgical patients has long been associated with malnutrition (71, 72) . Malnutrition is also regarded as a possible cause of MOF, cellular metabolism being limited by fuel deficiency with subsequent impairment in energy production, organ structure and function (8) .
Energy expenditure can be measured by calorimetry based on oxygen consumption and carbon dioxide production. It is generally calculated using the HarrisBenedict equations (73) multiplied by a stress factor (74), but such calculations tend to overestimate energy needs (75) and have been abandoned (75) . This is appropriate since the infusion of large quantities of glucose may exceed the maximal rate of glucose oxidation of 4-5 mg/kg/min (76), i.e. 400-500 grams/ day in a 70 kg patient. Hepatic lipogenesis, in particular, is stimulated by glucose excess (76) , with subsequent fat deposition and functional liver damage.
Large doses of carbohydrate also increase C0 2 production and may result in hypercarbia in patients with impaired pulmonary function (76, 77) . This may precipitate respiratory failure (78) , or may delay weaning from the ventilator (79, 80) .
Carbohydrate overfeeding may be avoided by providing 30-40% of non-protein calories as fat (7, 8, 79) . Many authors prefer fat administration (7, 40, 79, 80) , since energy metabolism is thought to depend on fat oxidation and fatty acid turnover is increased (28) . The continuous infusion of fat emulsion optimises metabolic benefits of lipids (79, 81) and prevents reticuloendotheli al system blockage and immunodepression (82, 83).
The potential benefits of fat on protein metabolism are still under evaluation, but a protein-sparing effect has been demonstrated in animal studies with alternative lipid sources such as medium-chain triglycerides (84) and structured triglycerides (85) . This observation is promising because nitrogen balance is seldom achieved in acute patients despite all efforts to provide an adequate nutritional support (28, 51) .
Since protein synthesis may be more sensitive to protein administration than to total calories (86) , it has been proposed to improve nitrogen balance by stimulating protein synthesis by increasing protein intake (87). However, recent studies have demonstrated that despite large quantities of protein and calories in excess of energy expenditure, body protein loss is almost unaltered (28, 88) and a significant portion of the infused aminoacids is directly catabolized in the liver. It appears therefore that nitrogen balance can be improved through an increase in dietary protein (28, 51, 88, 89) , but the rate of muscle protein catabolism is virtually unchanged and the amount of aminonitrogen to be disposed as urea is increased (51 ). Shaw and colleagues, in particular, have found that the net protein catabolism was reduced from 2.2 grams/kg/day when no protein was administered to 0.63 grams/kg/day when 1.1 grams/kg of protein was given with total parenteral nutrition in 17 septic patients. However, by increasing the rate of protein supply from 1.1 to 2.2 grams/kg/day, no further decrease in net protein catabolism was obtained, and optimal protein-sparing effect was observed with 1.5 grams of protein/kg b.w. Owing to these considerations the protein catabolic rate (PCR), which may be easily calculated by ureanitrogen kinetic modeling (90) , must be regarded more as an index of the severity of the catabolic stress than as a measure of protein requirements. Bistrian has proposed a stress index based on the difference between the measured urea nitrogen appearance (UNA) and dietary nitrogen intake (91) . Patients with a UNA 3-8 grams above nitrogen intake are considered to have a moderate catabolic stress, While patients with a UNA 8 grams or more over their dietary nitrogen intake have a severe metabolic stress.
Recommended protein intake in critically ill patients With ARF varies between 1.0 and 1.5 grams/kg b.w. depending on the degree of protein catabolism (7, 67, 92, 93) .
CONCLUSIONS
Understanding the metabolic status of all patients with acute renal failure is the most important element for a correct nutritional therapy. In patients with normal catabolism, treatment with a protein-restricted diet may be used to prevent uremic symptoms and avoid dialysis treatment. In hypercatabolic patients however, early dialysis must be instituted and a more complete nutritional support is needed to limit protein catabolism and prevent body protein losses.
When large volumes of fluid are required, conventional hemodialysis alone may not allow sufficient fluid removal and methods of continuous fluid removal may need to be used (94). Yet although nitrogen balance can be improved with nutritional support, in a substantial portion of acutely ill patients muscle proteolysis cannot be completely inhibited (28, 51, 88, 89) . Thus, nutritional treatment providing a caloric excess and a protein intake equal to protein catabolic rate seems to be too aggressive a measure to correct metabolic alterations in patients with acute renal failure. Future studies should address the mechanisms underlying this increased susceptibility to protein catabolism, so that more direct manoeuvres can be used to "down-regulate" catabolism in these severely ill patients. 
